Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
peginterferon alfa-2b 50 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
PEG-intron redipen 150 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
PEG-intron redipen 120 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
PEG-intron redipen 50 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
PEG-intron redipen 80 µg pulver + 0,5 ml sterilt vand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 150 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 50 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 80 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 100 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
peginterferon alfa-2b 120 µg pulver + solvens til injektionsvæske, opløsning, fyldt pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
Product containing peginterferon alfa-2b in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
|
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 100 microgram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Peginterferon alfa-2b only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Peginterferon alfa-2b only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 150 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Peginterferon alfa-2b (substance) |
Inferred relationship |
Some |
1 |